Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Microneedle Drug Delivery Systems Market, by Type
1.4.2 North America Microneedle Drug Delivery Systems Market, by Application
1.4.3 North America Microneedle Drug Delivery Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Industry Wide Strategic Developments - Global
3.1 Partnerships, Collaborations and Agreements
3.2 Product Launches and Product Expansions
3.3 Acquisition and Mergers
3.4 Geographical Expansions
3.5 Top Winning Strategies
3.5.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.5.2 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
Chapter 4. North America Microneedle Drug Delivery Systems Market by Type
4.1 North America Hollow Market by Country
4.2 North America Dissolving Market by Country
4.3 North America Solid Market by Country
4.4 North America Coated Market by Country
4.5 North America Other Types Market by Country
Chapter 5. North America Microneedle Drug Delivery Systems Market by Application
5.1 North America Drug delivery Market by Country
5.2 North America Cancer Therapy Market by Country
5.3 North America Vaccine delivery Market by Country
5.4 North America Pain Management Market by Country
5.5 North Dermatology Market by Country
5.6 North America Other Applications Market by Country
Chapter 6. North America Microneedle Drug Delivery Systems Market by Material
6.1 North America Metal Market by Country
6.2 North America Polymer Market by Country
6.3 North America Silicon Market by Country
6.4 North America Other Material Market by Country
Chapter 7. North America Microneedle Drug Delivery Systems Market by Country
7.1 USA Microneedle Drug Delivery Systems Market
7.1.1 USA Microneedle Drug Delivery Systems Market by Type
7.1.2 USA Microneedle Drug Delivery Systems Market by Application
7.1.3 USA Microneedle Drug Delivery Systems Market by Material
7.2 Canada Microneedle Drug Delivery Systems Market
7.2.1 Canada Microneedle Drug Delivery Systems Market by Type
7.2.2 Canada Microneedle Drug Delivery Systems Market by Application
7.2.3 Canada Microneedle Drug Delivery Systems Market by Material
7.3 Mexico Microneedle Drug Delivery Systems Market
7.3.1 Mexico Microneedle Drug Delivery Systems Market by Type
7.3.2 Mexico Microneedle Drug Delivery Systems Market by Application
7.3.3 Mexico Microneedle Drug Delivery Systems Market by Material
7.4 Rest of North America Microneedle Drug Delivery Systems Market
7.4.1 Rest of North America Microneedle Drug Delivery Systems Market by Type
7.4.2 Rest of North America Microneedle Drug Delivery Systems Market by Application
7.4.3 Rest of North America Microneedle Drug Delivery Systems Market by Material
Chapter 8. Company Profiles
8.1 Nitto Denko Corporation
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Geographical Expansions:
8.3 AdminMed nanoBioSciences LLC
8.3.1 Company Overview
8.4 Zosano Pharma Corporation
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.5 Raphas Co., Ltd.
8.5.1 Company Overview
8.6 Nanopass Technologies Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Corium Inc. (Gurnet Point Capital)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Zealand Pharma A/S (Valeritas, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.8.4 Recent strategies and developments:
8.8.4.1 Geographical Expansions:
8.9 Endoderma Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Geographical Expansions:
8.10. Innoture Medical Technology Limited
8.10.1 Company Overview
Unique Offerings 